How this fits in

This study presents a new cardiovascular disease microsimulation policy model that enables individualised lifetime predictions of disease risks, survival, and quality of life. The model quantified gaps at middle age of 4–5 years in life expectancy (5–8 quality-adjusted life years) across quintiles of socioeconomic deprivation in the UK. The study found that guideline-recommended statin treatment has a good potential to reduce health inequalities. Strengthening statin use would lead to larger benefits and further reductions in health inequalities.